Weiss Ratings Reaffirms Sell (E+) Rating for Strata Skin Sciences (NASDAQ:SSKN)

Strata Skin Sciences (NASDAQ:SSKNGet Free Report)‘s stock had its “sell (e+)” rating reaffirmed by stock analysts at Weiss Ratings in a research report issued on Saturday,Weiss Ratings reports.

Separately, Wall Street Zen upgraded Strata Skin Sciences to a “sell” rating in a research note on Saturday, October 18th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Strata Skin Sciences presently has a consensus rating of “Hold” and a consensus price target of $6.00.

View Our Latest Stock Analysis on SSKN

Strata Skin Sciences Price Performance

Strata Skin Sciences stock opened at $1.71 on Friday. The stock has a market cap of $9.01 million, a P/E ratio of -0.60 and a beta of 0.50. The company has a fifty day simple moving average of $1.87 and a 200-day simple moving average of $2.18. Strata Skin Sciences has a 12-month low of $1.38 and a 12-month high of $3.86. The company has a current ratio of 0.98, a quick ratio of 0.75 and a debt-to-equity ratio of 49.58.

Strata Skin Sciences (NASDAQ:SSKNGet Free Report) last announced its quarterly earnings results on Wednesday, August 13th. The medical device company reported ($0.60) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.33). The business had revenue of $7.70 million for the quarter, compared to analysts’ expectations of $8.56 million. Strata Skin Sciences had a negative return on equity of 266.94% and a negative net margin of 35.13%. Equities analysts expect that Strata Skin Sciences will post -1.05 EPS for the current fiscal year.

Strata Skin Sciences Company Profile

(Get Free Report)

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.

Featured Stories

Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.